CLGN - コルプラント・ホ―ルディングス (CollPlant Holdings Ltd.) コルプラント・ホ―ルディングス

 CLGNのチャート


 CLGNの企業情報

symbol CLGN
会社名 CollPlant Holdings Ltd (コルプラント・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Industrial Specialties  
業種    医療関連(Health Care)
概要 事業概要 --   コルプラント・ホ―ルディングスはイスラエルの再生医薬品メ―カ―。組織や器官の3Dバイオプリンティングに注力し、人体由来・天然性の材料を用いるオ―ソバイオロジクスや先進創傷ケア市場向けの組織修復用医薬品の開発・商業化に従事する。同社製品は遺伝子工学技術における独自の組み換え体ヒトコラ―ゲンに基づく。本社所在地はネスジオナ。   CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine. CollPlant recently entered a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
本社所在地 3 Sapir Street Weizmann Science Park Ness Ziona 74140 ISR
代表者氏名
代表者役職名
電話番号
設立年月日 2004年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 29人
url www.collplant.com
nasdaq_url https://www.nasdaq.com/symbol/clgn
adr_tso 149041
EBITDA EBITDA ー
終値(lastsale) 5.01
時価総額(marketcap) 746695.41
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 CLGNのテクニカル分析


 CLGNのニュース

   CollPlant Stock: Collagen, 3D Bioprinting, and BioInks  2021/06/20 16:40:48 Nanalyze
What attracts many new investors to the stock market is a really exciting story which involves the promise of future riches. Outside of pharmaceuticals stocks, you rarely find companies worth billions without meaningful revenues. We say meaningful because sometimes a company will generate small amounts of revenues forever without actually doing squat. Thats why we []
   CollPlant announces effectiveness of uplisting to Nasdaq Global Market  2021/06/04 11:16:47 Seeking Alpha
   CollPlant: CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs  2021/06/04 07:48:00 FinanzNachrichten
REHOVOT, Israel, May 25, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasd
   CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs  2021/06/04 00:00:00 BioSpace
CollPlant, a regenerative and aesthetic medicine company, announced the uplisting of its ordinary shares to the Nasdaq Global Select Market® effective at the open of market, Friday, June 4, 2021.
   CollPlant EPS beats by $0.08, misses on revenue  2021/05/27 11:27:18 Seeking Alpha
   CollPlant Stock: Collagen, 3D Bioprinting, and BioInks  2021/06/20 16:40:48 Nanalyze
What attracts many new investors to the stock market is a really exciting story which involves the promise of future riches. Outside of pharmaceuticals stocks, you rarely find companies worth billions without meaningful revenues. We say meaningful because sometimes a company will generate small amounts of revenues forever without actually doing squat. Thats why we []
   CollPlant announces effectiveness of uplisting to Nasdaq Global Market  2021/06/04 11:16:47 Seeking Alpha
   CollPlant: CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs  2021/06/04 07:48:00 FinanzNachrichten
REHOVOT, Israel, May 25, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasd
   CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs  2021/06/04 00:00:00 BioSpace
CollPlant, a regenerative and aesthetic medicine company, announced the uplisting of its ordinary shares to the Nasdaq Global Select Market® effective at the open of market, Friday, June 4, 2021.
   CollPlant EPS beats by $0.08, misses on revenue  2021/05/27 11:27:18 Seeking Alpha
   CollPlant announces effectiveness of uplisting to Nasdaq Global Market  2021/06/04 11:16:47 Seeking Alpha
   CollPlant: CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs  2021/06/04 07:48:00 FinanzNachrichten
REHOVOT, Israel, May 25, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasd
   CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs  2021/06/04 00:00:00 BioSpace
CollPlant, a regenerative and aesthetic medicine company, announced the uplisting of its ordinary shares to the Nasdaq Global Select Market® effective at the open of market, Friday, June 4, 2021.
   CollPlant EPS beats by $0.08, misses on revenue  2021/05/27 11:27:18 Seeking Alpha
   CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million  2021/05/27 00:00:00 BioSpace
CollPlant, a regenerative and aesthetic medicine company, announced financial results for the first quarter ended March 31, 2021 and provided an update on the Company''s business developments.

 関連キーワード  (― 米国株 コルプラント・ホ―ルディングス CLGN CollPlant Holdings Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)